We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pharmaceutical Care and Clinical Outcomes for the Elderly Taking Potentially Inappropriate Medication

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2009 by Shin Kong Wu Ho-Su Memorial Hospital.
Recruitment status was:  Enrolling by invitation
Sponsor:
ClinicalTrials.gov Identifier:
NCT00844025
First Posted: February 13, 2009
Last Update Posted: March 31, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Shin Kong Wu Ho-Su Memorial Hospital
  Purpose
The investigators propose that clinical pharmacist interventions would reduce the rate of adverse drug events in elderly patients taking potentially inappropriate medication.

Condition Intervention
Elderly Chronic Disease Behavioral: Pharmacist intervention

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Care Provider, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Pharmaceutical Care and Clinical Outcomes for the Elderly Taking Potentially Inappropriate Medication: a Randomized-Controlled Trial

Further study details as provided by Shin Kong Wu Ho-Su Memorial Hospital:

Primary Outcome Measures:
  • Number of unsolved drug-related problems [ Time Frame: 14 days after randomization ]

Secondary Outcome Measures:
  • Rate of adverse drug event during hospitalization [ Time Frame: 14 days after randomization ]
  • Number of potentially inappropriate medication [ Time Frame: 14 days after randomization ]

Estimated Enrollment: 120
Study Start Date: February 2009
Estimated Study Completion Date: February 2010
Estimated Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Pharmacist intervention
Patients in the intervention group will receive pharmaceutical care delivered by clinical pharmacist, which including medication review, medication reconciliation, patient education and recommended actions.
Behavioral: Pharmacist intervention
Medication review, medication reconciliation, and pharmacotherapy recommendation.
No Intervention: Usual care
Patients randomized to usual care group will receive routine review of medication by ward-based pharmacist and nurse.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   65 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Hospitalized patients aged at least 65 years
  • Taking at least six prescribed medicines regularly, including at least one potential inappropriate medication

Exclusion Criteria:

  • Patients who refused informed consent
  • Discharged before consent could be obtained
  • Cognitive impaired
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00844025


Locations
Taiwan
Shin Kong Wo Ho-Su Memorial Hospital, Department of Pharmacy
Taipei, Taiwan, 111
Sponsors and Collaborators
Shin Kong Wu Ho-Su Memorial Hospital
Investigators
Principal Investigator: Liu Jen Wei, MS Shin Kong Wo Ho-Su Memorial Hospital
  More Information

Publications:
Responsible Party: Tsai Ming Dar/Chief of Shin Kong Wu Ho-Su Memorial Hospital Research and Education Assessment Department, Shin Kong Wu Ho-Su Memorial Hospital
ClinicalTrials.gov Identifier: NCT00844025     History of Changes
Other Study ID Numbers: SKH-8302-98-NDR-05
First Submitted: February 12, 2009
First Posted: February 13, 2009
Last Update Posted: March 31, 2009
Last Verified: March 2009

Keywords provided by Shin Kong Wu Ho-Su Memorial Hospital:
Adverse drug reaction
Inappropriate medication
Pharmacist
Pharmaceutical care

Additional relevant MeSH terms:
Chronic Disease
Disease Attributes
Pathologic Processes